Skip to main content

Table 1 Recipients’ characteristics

From: Improved long-term outcomes after heart transplantation utilizing donors with a traumatic mode of brain death

  Non-traumatic brain death
(N = 85)
Traumatic brain death
(N = 105)
p-value
Gender (male, %) 75.4 83.5 0.217
Age (years) 47.4 ± 14.7 46.9 ± 13.9 0.331
Weight (kg) 72.0 ± 19.1 73.6 ± 15.1 0.717
Height (cm) 165.5 ± 27.1 170.9 ± 12.2 0.725
BMI 24.3 ± 4.4 24.8 ± 4.6 0.578
Ischemic etiology for HTx (%) 49.2 54.1 0.622
Hypertension (%) 20.0 27.6 0.221
Diabetes pre (%) 18.5 18.8 0.955
Dyslipidemia (%) 37.9 44.3 0.405
Past smoker (%) 38.2 35.6 0.826
CMV positive serology (%) 91.2 93.6 0.742
Status prior to transplantation (%)    0.228
 Status 1 70.8 60.0  
 Status 2 29.2 40.0  
Creatinine (mg/dL) 1.4 ± 1.1 1.2 ± 0.5 0.209
Bilirubin (mg/dL) 1.2 ± 0.8 1.1 ± 0.6 0.234
Systolic blood pressure (mmHg) 128.1 ± 22.1 129.1 ± 11.0 0.133
Diastolic blood pressure (mmHg) 73.2 ± 12.8 75.2 ± 11.6 0.257
Systolic PAP (mmHg) 54.1 ± 19.3 49.1 ± 20.1 0.405
Diastolic PAP (mmHg) 26.3 ± 10.8 24.4 ± 11.3 0.883
Mean PAP (mmHg) 36.7 ± 14.5 34.9 ± 13.9 0.994
PCWP 25.4 ± 11.3 25.1 ± 11.2 0.712
CO 3.5 ± 1.1 3.5 ± 1.1 0.671
PVR 3.1 ± 2.0 2.9 ± 2.5 0.871
ICD (%) 35.9 36.1 0.979
LVAD bridge to HTx 23.7 17.6 0.410
PRA > 30% 1.6 3.1 0.351
CMV mismatch 46.2 36.5 0.245
Blood type    0.713
 A 46.8 45.8  
 AB 8.6 16.3  
 B 13.3 22.4  
 O 26.9 19.4  
  1. BMI Body mass index, HTx Heart transplantation, CMV Cytomegalovirus, PAP Pulmonary artery pressure, PCWP Pulmonary capillary wedge pressure, CO Cardiac output, PVR Pulmonary vascular resistance, ICD Implantable cardioverter defibrillator, LVAD Left ventricular assist device, PRA Panel reactive antibody